Skip to main content
. 2019 Jan 19;68(4):545–551. doi: 10.1007/s00262-019-02298-9

Table 3.

Response to treatment at week 16 and survival of elderly and young patients included in the study

Elderly patients Younger patients
Number of patients 23 29
Response at week 16: n (%)
 Complete response 0 (0) 1 (3)
 Partial response 3 (13) 1 (3)
 Stable disease 9 (39) 10 (34)
 Progressive disease 11 (48) 17 (59)
Disease control rate at week 16 52% 41%
Response rate at week 16 13% 6%
Median progression-free survival (months) 4 4
Median overall survival (months) 14 17